Capillary leak syndrome induced by neoadjuvant cisplatin and gemcitabine in a patient with bladder cancer

Capillary leak syndrome (CLS) is a rare disorder associated with an increased capillar permeability due to an endothelial damage, causing leakage of plasma and proteins into the interstitial compartment. CLS is characterized by rapidly developing edema, hypotension and hypoproteinemia. We observed C...

Full description

Saved in:
Bibliographic Details
Published in:Urology case reports 2021-01, Vol.34, p.101461, Article 101461
Main Authors: Massafra, Marco, Passalacqua, Maria Ilenia, Lupo, Giuseppe, Altavilla, Giuseppe, Santarpia, Mariacarmela
Format: Article
Language:English
Subjects:
Bladder cancer
Capillary leak syndrome
Gemcitabine
Oncology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Capillary leak syndrome (CLS) is a rare disorder associated with an increased capillar permeability due to an endothelial damage, causing leakage of plasma and proteins into the interstitial compartment. CLS is characterized by rapidly developing edema, hypotension and hypoproteinemia. We observed CLS in a 54-year-old man affected by muscle-invasive bladder cancer who received neoadjuvant treatment with Cisplatin and Gemcitabine. Treatment with infusion of albumin and increasing corticosteroid doses and diuretics led to a complete regression of all signs and symptoms related to the disorder. Of note, the patient showed an objective complete response to chemotherapy and underwent radical surgery on schedule.
ISSN:2214-4420
2214-4420
DOI:10.1016/j.eucr.2020.101461